Reaction
Pik3Ca-Activated Mutation reporting signals
As of the last recalculation, Pik3Ca-Activated Mutation appears in 322 FAERS reports alongside 24 co-occurring drug terms. The strongest observed disproportionality signal is FULVESTRANT (PRR 677.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Fulvestrant | 167 | 677.8 | 681.2 |
| Letrozole Tablets | 168 | 470.9 | 472.6 |
| Letrozole | 182 | 438.0 | 439.3 |
| Exemestane | 83 | 337.1 | 338.4 |
| Goserelin | 55 | 319.1 | 320.4 |
| Alpelisib | 37 | 309.9 | 311.2 |
| Everolimus Tablets | 56 | 261.1 | 262.0 |
| Ribociclib | 88 | 247.6 | 248.3 |
| Anastrozole Tablets | 47 | 165.6 | 166.0 |
| Capecitabine | 107 | 112.7 | 112.8 |
| Everolimus | 68 | 109.2 | 109.4 |
| Anastrozole | 50 | 104.0 | 104.2 |
| Palbociclib | 102 | 100.7 | 100.8 |
| Paclitaxel | 89 | 79.9 | 80.0 |
| Paclitaxel (Aibumin-Bound) | 72 | 72.6 | 72.7 |
| Abemaciclib | 20 | 68.9 | 69.0 |
| Gemcitabine Hydrochloride | 43 | 60.3 | 60.4 |
| Zoledronic Acid | 33 | 59.1 | 59.1 |
| Gemcitabine | 29 | 52.2 | 52.2 |
| Docetaxel Anhydrous | 31 | 32.8 | 32.8 |
| Docetaxel | 31 | 32.8 | 32.8 |
| Denosumab | 75 | 30.9 | 30.9 |
| Lapatinib | 7 | 29.8 | 29.8 |
| Panitumumab | 7 | 29.5 | 29.5 |